Trial intelligence / Profile preview

Fluconazole vs Amphotericin B for Cryptococcal Meningitis Relapse Prevention

NCT00002074Phase 3Completed

Sponsor
Pfizer
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 3 trial of fluconazole in cryptococcal meningitis, sponsored by Pfizer. Status: completed.

02

Drugs

fluconazole
03

Conditions

cryptococcal meningitis

Beyond the preview

Go deeper on NCT00002074.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002074.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call